For the National Breast Cancer Coalition (NBCC), ensuring quality research means working consistently, year after year, to ensure adequate federal appropriations for high-quality, peer-reviewed research.
In addition, NBCC is committed to making sure those hard-won research funds are well-spent and that relevant research in the private sector addresses the needs of breast cancer patients. NBCC accomplishes this by demanding advocate representation on all relevant review committees and panels and through collaborations with the scientific community.
With these scientific-community collaborations, NBCC works to develop new research models, conduct research, design protocols, set research priorities and conduct research aimed at ending breast cancer.
As a grassroots organization, NBCC recognizes the importance of an empowered public and providing the public with evidence-based and patient-centered information on important breast cancer issues and research. This has been a key focus for NBCC since our founding.
What we know about breast cancer evolves over time, as more and more research is done asking the important questions about how it develops, how we might prevent it and which treatments are most effective for which patients.
We want breast cancer care—and all health care—to be based on the strongest evidence of what will work and what will be safe.
08/25/20We all want immunotherapy to “work” for breast cancer patients. For the National Breast Cancer Coalition, that means therapy that will significantly prolong survival without adverse impact on quality of life. We expect that the evidence of that benefit will be shown by well-designed, well conducted prospective randomized clinical trials, sufficiently powered to support that result. The tale of atezolizumab shows us we are not there yet.